Related Experiment Video
Updated: Aug 15, 2026

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Functional constraints on the constitutive androstane receptor inferred from human sequence variation and
Emma E Thompson1, Hala Kuttab-Boulos, Matthew D Krasowski
1Committee on Genetics, University of Chicago, Chicago, IL 60637, USA.
Abstract:
Members of the NR1I subfamily of nuclear receptors play a role in the transcriptional activation of genes involved in drug metabolism and transport. NR1I3, the constitutive androstane receptor (CAR), mediates the induction of several genes involved in drug response, including members of the CYP3A, CYP2B and UGT1A subfamilies. Large inter-individual variation in drug clearance has been reported for many drug metabolising enzyme genes. Sequence variation at the CAR locus could potentially contribute to variation in downstream targets, as well as to the substantial variation in expression level reported. We used a comparative genomics-based approach to select resequencing segments in 70 subjects from three populations. We identified 21 polymorphic sites, one of which results in an amino acid substitution. Our study reveals a common haplotype shared by all three populations which is remarkably similar to the ancestral sequence, confirming that CAR is under strong functional constraints. The level and pattern of sequence variation is approximately similar across populations, suggesting that interethnic differences in drug metabolism are not likely to be due to genetic variation at the CAR locus. We also identify several common non-coding variants that occur at highly conserved sites across four major branches of the mammalian phylogeny, suggesting that they may affect CAR expression and, ultimately, the activity of its downstream targets.
Insights
Genetic variations in the constitutive androstane receptor (CAR) gene show limited interethnic differences, suggesting other factors influence drug metabolism. Conserved non-coding variants may impact CAR gene expression and drug response.
Area of Science:
- Pharmacogenomics
- Molecular biology
- Genetics
Background:
- Nuclear receptors, including NR1I3 (constitutive androstane receptor or CAR), regulate genes vital for drug metabolism and transport.
- Significant inter-individual variability exists in drug clearance, partly due to genetic factors influencing drug-metabolizing enzymes like CYP3A, CYP2B, and UGT1A.
- Genetic variations within the CAR locus could explain differences in gene expression and drug response.
Purpose of the Study:
- To investigate sequence variation in the CAR gene across different populations.
- To determine if genetic variations in CAR contribute to interethnic differences in drug metabolism.
- To identify potential regulatory variants affecting CAR expression.
Main Methods:
- Comparative genomics was used to select resequencing regions in 70 individuals from three distinct populations.
- DNA sequencing was performed to identify polymorphic sites within the CAR gene.
- Phylogenetic analysis was employed to assess the conservation of identified variants.
Main Results:
- Twenty-one polymorphic sites were identified in the CAR gene, with one leading to an amino acid substitution.
- A common haplotype, highly similar to the ancestral sequence, was found across all populations, indicating strong functional constraints on CAR.
- Sequence variation patterns were similar across populations, suggesting CAR genetic variation is not a primary driver of interethnic drug metabolism differences.
- Several conserved non-coding variants were identified, potentially influencing CAR expression.
Conclusions:
- Genetic variation at the CAR locus does not appear to be a major cause of interethnic differences in drug metabolism.
- Conserved non-coding variants in the CAR gene may play a role in regulating its expression and downstream drug-metabolizing enzyme activity.
- Further research into these non-coding variants could provide insights into personalized medicine and drug response variability.
More Related Videos
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Ligand Binding and Linkage
Cis-regulatory Sequences
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with one...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Cell Signaling in Plants